Status:
COMPLETED
A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency
Lead Sponsor:
Walter Reed Army Institute of Research (WRAIR)
Conditions:
Glucosephosphate Dehydrogenase Deficiency
Favism
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
This study will evaluate a new and safe testing method for identifying medicines that can cause problems in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals. We are looking for volunteer...
Eligibility Criteria
Inclusion
- Inclusion:
- Normal clinical evaluation
- Willing and able to make all scheduled visits
- Exclusion:
- pregnant or planning pregnancy
- Have taken any anti-malarial medication in past month
- Positive blood tests for HIV and specific types of hepatitis
- Allergic to primaquine
Exclusion
Key Trial Info
Start Date :
December 1 2003
Trial Type :
INTERVENTIONAL
End Date :
November 1 2006
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT00076323
Start Date
December 1 2003
End Date
November 1 2006
Last Update
July 27 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Walter Reed Army Institute of Research
Silver Spring, Maryland, United States, 20910